Certified by Founder Lodge
Redmile Group
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $150,000,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Redmile Group is a company based out of San Francisco.
| Company | Date | Round | Raised |
|---|---|---|---|
 Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 ElevateBio |
May, 25 ,2023 | Series D | $401,000,000 |
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
 Star Therapeutics |
September, 05 ,2023 | Series C | $90,000,000 |
 Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
 GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
4D Biomaterials | $4,373,097 | (Jul 26, 2024)
TRiCares GmbH | $50,000,000 | (Jul 26, 2024)
Micropep Technologies | $29,000,000 | (Jul 26, 2024)
GEOH | $3,000,000 | (Jul 26, 2024)
SirenOpt | $6,600,000 | (Jul 26, 2024)
